Skip to Content

APO MOE 15 (Moexipril 15 mg)

Pill imprint APO MOE 15 has been identified as Moexipril hydrochloride 15 mg.

Moexipril is used in the treatment of diabetic kidney disease; left ventricular dysfunction; high blood pressure; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Moexipril hydrochloride 15 mg APO MOE 15
Moexipril hydrochloride 15 mg APO MOE 15
Discount Card Promo
Moexipril hydrochloride
Imprint:
APO MOE 15
Strength:
15 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0272
Inactive Ingredients:
magnesium carbonate
crospovidone
copovidone
zinc stearate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide